Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthBlue Cross Blue Shield WI TMS Prior Auth Policy | …
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - WisconsinPolicy N/A

    Transcranial Magnetic Stimulation (TMS) request and authorization form

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - Wisconsin policy alerts

    Know when Blue Cross Blue Shield - Wisconsin releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    A provider-facing request form used to collect clinical, device, treatment-parameter, and prior-treatment information to support prior authorization of TMS (including rTMS and theta burst) for members of participating Blue Cross Blue Shield plans in listed states.

    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyTranscranial Magnetic Stimulation (TMS) request and authorization form
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewMar 1, 2026
    Next Review DateN/A
    Key ActionComplete and submit the TMS request form (including required prior-treatment documentation) to obtain prior authorization before starting treatment.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    30standard acute course (max)

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    >=18
    minimum age
    2+ classesprior antidepressant trials
    30 cmdevice exclusion distance

    Coverage Criteria for TMS

    Initial TMS therapy

    Covered when ALL of the following are met

    Age: Individual is 18 years or older>=18 years

    Captured on form

    Diagnosis: Confirmed diagnosis of severe treatment‑resistant major depressive disorder (single or recurrent episode)severe treatment‑resistant MDD

    Form asks to mark confirmed diagnosis

    Prior pharmacotherapy: Inadequate response to at least two antidepressant trials from different classes with adequate dose and duration, documented adherence, or inability to tolerate two trials>=2 classes

    Medication trial details (dates, dose, duration, outcome, adherence) must be listed on form

    Device and parameters: TMS to be administered by an FDA‑approved device using specified rTMS or TBS protocols; standard acute course not to exceed five days/week for six weeks (30 sessions) followed by a taper<=30 sessions standard acute course

    Device type and treatment protocol recorded on form

    Safety: No implanted magnetic‑sensitive medical device or other contraindicated metal device located <=30 cm from the TMS coil unless specifically addressed>30 cm clearance preferred

    Form lists specific devices (cochlear implant, ICD, pacemaker, VNS, DBS, aneurysm clips/coils/staples/stents) to check

    Continuation and maintenance

    Continuation or maintenance treatment considerations

    Maintenance vs Continuation: Form requests whether request is for maintenance (after remission >=2 months) or continuation (up to 6 months to prevent worsening prior to remission)

    Different documentation and prior response requirements apply

    Prior TMS response for maintenance: For maintenance, member must have had prior response to TMS defined by 50% reduction in symptom severity on a standardized rating scale and recurrence based on clinically meaningful worsening50% reduction

    Form collects initial and final standardized rating scales and dates

    Implanted magnetic‑sensitive medical devices or other metal objects located within 30 centimeters of the TMS coil are listed on the form as a safety concern and may preclude treatment. Examples called out on the form include cochlear implants, implanted cardioverter defibrillators (ICDs), pacemakers, vagus nerve stimulators (VNS), deep brain stimulators, and metal aneurysm clips/coils/staples/stents. Dental amalgam fillings are specifically noted as acceptable.

    Billing and Coding

    Requested CPT CodesCPT
    90867Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; initial, including cortical mapping, motor threshold determination, delivery, and management
    90868Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; subsequent delivery and management, per session
    Standard acute course sessions — key value (30 sessions)
    Standard acute course (maximum)30 sessions (up to 5 days/week for 6 weeks)
    Typical scheduleUp to 5 sessions per week for ~6 weeks (then a taper)
    Documented on formForm asks provider to confirm standard course will not exceed five days/week for six weeks (30 sessions)

    Provider Actions and Documentation Requirements

    Prior Authorization

    Prior authorization required — submit completed TMS request form with CPT codes

    Complete and fax or submit the TMS request form (including the requested CPT codes) to obtain prior authorization before starting treatment. The form lists CPT 90867 for initial TMS (including cortical mapping and motor threshold determination) and 90868 for subsequent per‑session delivery and management.

    • Fax completed form to 866-834-7469 or submit via https://Availity.com
    • Include requested CPT codes 90867 (initial) and 90868 (subsequent) on the form
    Step Therapy

    Document prior pharmacotherapy — at least two adequate antidepressant trials

    Document that the individual has had inadequate response to pharmacotherapy consisting of trials with two or more antidepressant classes, including adequate dose and duration and documented adherence; alternatively document inability to tolerate two trials with side effects.

    • List each medication trial on the form with date of trial, maximum dose, duration, outcome, side effects, and adherence

    Background

    This request form is used to obtain prior authorization for Transcranial Magnetic Stimulation (TMS) therapies — including repetitive TMS (rTMS) and theta burst stimulation (TBS) — for adults with severe major depressive episodes. The form collects the clinical information needed to determine coverage, including patient demographics and age, confirmed diagnosis, documentation of prior pharmacotherapy trials (number, dose, duration, and adherence), prior response to TMS when applicable, the specific device and stimulation parameters to be used, and the requested CPT codes and number of sessions.

    Providers must complete and submit the form (including requested CPT codes such as 90867 for the initial session and 90868 for subsequent sessions) and include supporting documentation as indicated — for example, medication trial history, psychiatric evaluation or TMS intake evaluation within three months, and standardized rating scales when relevant — to support authorization and verification of criteria such as age (adult), inadequate response to at least two antidepressant classes, and device safety considerations.

    The form also captures treatment-plan details and limits: whether TMS will be delivered by an FDA‑approved device (and which device), the intended stimulation modality (rTMS or TBS), and that the standard acute course is not to exceed five days per week for six weeks (a total of 30 sessions), followed by tapering when appropriate.

    Definitions

    Maintenance treatment — definition and full remission criteria
    Definition — Maintenance treatmentTreatment that continues after remission has been achieved; full remission refers to no significant signs or symptoms of major depression for at least two months.
    When to requestForm asks whether request is for maintenance TMS treatment after documented remission.
    DocumentationProvide evidence of prior remission duration and clinical status to support maintenance request.
    Continuation treatment — definition (post-acute, up to six months)
    Definition — Continuation treatmentCourse that begins after the acute/index course, lasts up to six months, and is designed to prevent worsening of symptoms and continue treatment for a depressive episode that has not yet remitted.
    Duration limit

    Level of Care

    Outpatient

    Outpatient TMS Admission: Adult with severe, treatment‑resistant MDD, failed >=2 antidepressant classes or intolerant, appropriate FDA‑approved device, and no proximal incompatible implanted device

    Form documents criteria

    Continued TMS course: Treatment follows standard acute course up to 30 sessions over approximately 6 weeks; continuation or maintenance requests must meet definitions captured on form and document prior response or recurrence<=30 sessions for acute course; continuation up to 6 months

    Form captures response, treatment dates, and medication trials

    Treatment Modalities

    TMS / rTMS / TBS

    Modalities captured: Requests can indicate theta burst stimulation (TBS) and high‑frequency or low‑frequency rTMS protocols (frequencies <1 Hz to 20 Hz)

    Form contains checkboxes for TBS and rTMS types and space to specify protocol

    Visit Limits and Session Counts

    TMS sessions — standard acute course maximum (30 sessions)
    Standard acute course maximum30 sessions total (standard course not to exceed five days/week for six weeks)
    Scheduling noteTypically delivered up to 5 days per week for ~6 weeks, followed by a taper as indicated.
    Form confirmationForm includes a checkbox to confirm the standard treatment course will not exceed 30 sessions.
    Policy Summary
    PayerBlue Cross Blue Shield - Wisconsin
    PolicyTranscranial Magnetic Stimulation (TMS) request and authorization form
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewMar 1, 2026
    Next Review DateN/A
    Key ActionComplete and submit the TMS request form (including required prior-treatment documentation) to obtain prior authorization before starting treatment.
    SourceLink
    On This Page
    Coverage Criteria for TMSBilling and CodingProvider Actions and Documentation RequirementsBackgroundDefinitionsLevel of CareTreatment ModalitiesVisit Limits and Session Counts
  1. Specify if intolerance to two trials is the reason for proceeding to TMS
  2. Documentation Required

    Required documentation — completed form (plus optional recent evaluations)

    Submit the completed TMS request form; you may also include a copy of the TMS intake evaluation or a full psychiatric evaluation performed within three months of the requested start date to support the authorization, but these do not replace the required form.

    • Include any relevant standardized rating scales, device type, and treatment parameters on the form
    • Additional evaluations (TMS intake or psychiatric evaluation) may be attached if within 3 months of requested start
    Denial Risk

    Implanted magnetic‑sensitive device proximity — exclusion/denial risk if ≤30 cm from coil

    Marking that the individual has an implanted magnetic‑sensitive medical device or other metal item located less than or equal to 30 centimeters from the TMS coil is a safety exclusion and may preclude treatment or result in denial if not addressed.

    • The form lists specific devices to check (e.g., cochlear implant, ICD, pacemaker, VNS, deep brain stimulator, metal aneurysm clips/coils/staples/stents)
    • Dental amalgam fillings are explicitly acceptable and not affected
    Up to 6 months following the acute/index course.
    PurposePrevent worsening of symptoms when a depressive episode has not yet remitted.
    Member responded to initial treatment — response defined as 50% reduction on standardized scale
    Response thresholdMember response defined as a 50% reduction in symptom severity on a standardized rating scale (relative to pretreatment), with recurrence defined by clinically meaningful worsening relative to best TMS response.
    Evidence requiredForm requests initial and final standardized rating scale scores with dates to document the 50% reduction.
    Use for maintenance eligibilityPrior response (50% reduction) plus clinically meaningful recurrence is required for maintenance requests.